Creavo Medical Technologies Ltd of Coventry at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Creavo Medical Technologies Ltd

2020 House, Siskin Drive, Middlemarch Business Park, CV3 4FJ Coventry
United Kingdom of Great Britain and Northern Ireland
Telephone +44 1926 670560

Hall map

MEDICA 2018 hall map (Hall 9): stand C42

Fairground map

MEDICA 2018 fairground map: Hall 9

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.14  Heart circulation diagnostics equipment

Heart circulation diagnostics equipment

Our products

Product category: Heart circulation diagnostics equipment

CORSENS Inteligence for life

Corsens® is a platform technology that measures, displays and reports electromagnetic fluctuations generated by the activity of the heart.

Creavo’s first product to market, Corsens®, will enable healthcare professionals to use the device as an aid to rapidly and accurately rule out patients attending the emergency department with symptoms consistent with those of acute coronary syndrome.

Corsens® an aid to rule out
A majority of patients presenting to emergency departments with chest pain do not get diagnosed with acute coronary syndrome2. However, most will still follow the extensive chest pain pathway – increasing pressure on already strained clinical resources. With Corsens®, healthcare professionals can utilise the MCG results as an aid to rule out active ischaemia in patients presenting with symptoms consistent with those of acute coronary syndrome and direct them to the most appropriate care pathway.
This is achieved by detecting distortions in the heart’s magnetic field caused by the presence of ischaemic (lacking oxygen) or necrotic (dead) cells which can be clearly observed in the resulting MCG field map and trace score.

2 Backus et al. 2011; Rohacek et al. 2012; Six et al. 2012; Backus et al. 2013

More Less

About us

Company details

A vision to transform cardiology
We believe our technology has the power to transform the way that heart disease is identified and subsequently treated. Through our ground breaking MCG technology, we aim to reduce the economic burden on healthcare systems worldwide.

More Less